Susan L. Koletar, MD, FACP

Professor, Internal Medicine

E-mail: koletar.1@osu.edu

Recent Publications

MacGregor RR, Hafner R, Wu JW, Murphy RL, Perlman DC, Bermudez LE, Inderlied CB, Picker LJ, Wallis RS, Andersen JW, Mahon LF, Koletar SL, Peterson DM; ACTG Protocol 341 Team. Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study. AIDS Res Hum Retroviruses. 2005 Aug;21(8):689-95.

Joy S, Poi M, Hughes L, Brady M, Koletar SL, Para MF, Fan-Havard P. Third Trimester Maternal Toxicity with Nevirapine Use in Pregnancy. Obstetrics & Gynecology 2005;106(5, Part 1):1032-1038.

Gulick RM, Ribaudo HJ, Shikuma CM, Lalama C, Schackman BR, Meyer WA, Acosta EP, Schouten J, Squires KE, Pilcher CD, Murphy RL, Koletar SL, Carlson M, Reichman RC, Bastow B, Klingman KL, Kuritzkes DR, for the AIDS Clinical Trials Group A5095 Study Team. Three- vs. Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection. A Randomized Controlled Trial.  JAMA 2006; 296:769-781.

Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Collier AC, Fielding R, Alston-Smith B, Basar M, Grinspoon S for the ACTG 5082 Study Team. Effects of Metformin and Rosiglitazone in HIV-Infected Patiens with Hyperinsulinemia and Elevated Waist/Hip Ratio: A Randomized Double-Blind, Placebo-Controlled Multicenter Trial (ACTG 5082). AIDS 2007;21(1):47-57.

Young JD, Mangino JE, Stevenson KB, Koletar SL. Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis. Clin Infect Dis. 2007; 44(1):152.

Kuritzkes DR, Ribaudo HJ, Squires KE, Koletar SL, Santana J, Riddler SA, Reichman R, Shikuma C, Meyer W, Klingman K, Gulick RM for the ACTG A5166s Protocol Team. Relationship of plasma HIV-1 RNA dynamics to treatment regimen andsex in antiretroviral-naïve subjects receiving either triple-nucleoside or efavirenz-containing regimens: AIDS Clinical Trials Group protocol A5166s. J Inf Dis 2007;195(8):1169-76.

Gulick RM, Lalama C, Ribaudo HJ, Shikuma C, Schackman BR, Shouten J, Squires KE, Acosta EP, Meyer WA, Koletar SL, Pilcher CD, Reichman RC, Santa JL, Hughes V, Bastow B, Klingman K, Kuritzkes DR for the ACTG 5095 Study Team. Intensification of a Triple Nucleoside Regimen with Tenofovir or Efavirenz in HIV-Infected Subjects with Virologic Suppression (AIDS Clinical Trials Group Study A5095) AIDS 2007; 21(7):813-23.

McCutchan JA, Wu JW , Robertson K, Koletar SL, Ellis RE, Cohn SE, Taylor M, Woods S, Heaton R, Murphy RL, Currier JS and Williams PL, for the ACTG 362 Team. HIV Suppression by HAART Preserves Cognitive Function in Advanced, Immune-Reconstituted AIDS Patients. AIDS 2007;21(9):1109-1117.

Acosta EP, Kendall MA, Gerber JG, Alston-Smith B, Koletar SL, Zolopa AR, Agarwala S, Child M, Bertz R, Hosey L, Haas DW. Effect of Concomitant Rifampin on the Pharmacokinetics and Safety of Twice-Daily Atazanavir: ACTG Protocol A5213. Antimicrob Agents Chemother 2007; 51(9):3104-10.

Sattler FR, Rajicic N, Mulligan K, Yarasheski K, Koletar SL, Zolopa A, Alston-Smith B, Zackin R, Bistrian B for the ACTG 392 Team.  Evaluation of High Protein Supplementation in HIV Positive Subjects with Stable Weight Loss: a Randomized, Double-Blind, Multicenter Trial. [Re-submitted with revisions: American Journal of Clinical Nutrition]

Williams PL, Wu J, Cohn SE, Koletar SL, McCutchan JA, Murphy RL, and Currier JS for the AIDS Clinical Trials Group 362 Study Team. Incidence and Predicted Risk of Cardiovascular Disease in HIV-infected Adults with Immune Reconstitution.  [Submitted: Antiviral Therapy].

Fan-Havard P, Franco A, Joy SD, Hunkler J, Brady MT, Koletar SL, Para MF, Kang SK, Poi Ming, and Lamberjack K.  The Provision of Seamless Care to HIV-Infected Pregnant Women: Implementation of a Multidisciplinary HIV Pregnancy Program. [Submitted: Annals of Pharmacotherapy]